"This is the Beginning of the End of the Pandemic" - NJ Hydroxycholoroquine Study a "Game Changer"

essentialsaltes said:

Doocy went on to play a clip of Dr. Oz wondering whether Fauci was impressed with the results of that study.

Click to expand...

But Trump has told officials that it would be “a good idea” if they talked to Oz, one of the sources added. Top administration officials, including Trump’s administrator of the Centers for Medicare and Medicaid Services, Seema Verma, have privately spoken to Oz in recent days to discuss the virus and his views on the possible treatment, three sources said. The New York Times first reported that Oz had been in touch with the Trump team.

Subduction Zone said:

Late last night I read in the Washington Post that it appears that Rudy is Trump's science advisor.

Click to expand...

Imagine traveling 5 years back in time and saying this sentence in public...

wing2000 said:

Can you explain why the POTUS is misrepresenting just one potential treatment -- repeatedly for several days?

Click to expand...

A bigger question - why would anyone get scientific advise from a guy who had to be reminded not to stare at a solar eclipse?

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Sounds promising.

Of the Raoult study in France

Since the patients were in the ICU or dead, their samples could not be taken and they were left out of the final analysis. Based on the nasal swabs of just the 36 patients who completed the study, those who received the drug cleared the virus from their systems faster than those who did not.

This is how an experiment in which 15% of the treatment group and 0% of the control had poor clinical outcomes could end up being reported as showing a “100% cure rate”.

On 3 April, two weeks after the study was first published online, the International Society of Antimicrobial Chemotherapy, which publishes the IJAA, said in a statement that the group’s board “believes the article does not meet the Society’s expected standard, especially relating to the lack of better explanations of the inclusion criteria and the triage of patients to ensure patient safety”.

And another success story from the US

Zanting said:

And another success story from the US

Click to expand...

...and he carefully qualified his statement.